Related Experiment Video
Updated: Sep 14, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Application of vitamin B6 in diabetic cardiomyopathy through modulation of endoplasmic reticulum stress
Chun-Rui Zhang1, Ze-Yu Yang2, Meng-Yao Zhao3
1College of Pharmacy, Henan Medical University, Xinxiang, China.
Abstract:
Diabetic cardiomyopathy (DCM) is an independent heart disease characterized by myocardial hypertrophy, dysfunction, and fibrosis, leading to heart failure. While current treatments focus on blood glucose regulation, there are limited interventions targeting the underlying molecular mechanisms. Endoplasmic reticulum stress (ERS) is a critical factor linking metabolic disturbances to myocardial injury. Prolonged high glucose (HG) or lipid conditions exacerbate the unfolded protein response, which activates the PERK-eIF2α-ATF4-CHOP axis. Although vitamin B6 (VitB6) (pyridoxal 5'-phosphate) is known to regulate stress responses, its role in DCM remains unclear. This study investigates the protective effects of VitB6 in DCM and examines whether these effects are associated with changes in S1P1, extracellular signal-regulated kinase (ERK)/cAMP response element-binding protein (CREB) phosphorylation, sirtuin 1 (SIRT1) expression, and ERS. DCM rat models and HG-induced H9c2 cells were treated with VitB6. Heart function, fibrosis, and ultrastructural changes were evaluated. ERS markers and signaling components (S1P1, SIRT1, ERK, and CREB) were assessed. The contribution of S1P1 to VitB6-associated ERK activation was further assessed using the S1P1 inhibitor APD334. VitB6 improved heart function, reduced fibrosis, and attenuated ERS in DCM rats. These effects were accompanied by restoration of S1P1 and SIRT1 expression and increased ERK/CREB phosphorylation. In H9c2 cells, VitB6 alleviated HG-induced stress and produced concordant changes in these signaling components. Pharmacological inhibition of S1P1 attenuated the VitB6-associated increase in ERK phosphorylation, supporting the involvement of S1P1 in ERK activation under these experimental conditions. VitB6 mitigates DCM-associated injury and is accompanied by restoration of S1P1 expression, ERK/CREB phosphorylation, and SIRT1 expression, together with attenuation of ERS. These findings suggest the involvement of an S1P1-related ERK/CREB-SIRT1 regulatory network, while the precise causal hierarchy and direct molecular links remain to be established.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Cardiomyopathy V: Interprofessional Care